W. Cameron Black

3.7k total citations
42 papers, 1.9k citations indexed

About

W. Cameron Black is a scholar working on Molecular Biology, Organic Chemistry and Cancer Research. According to data from OpenAlex, W. Cameron Black has authored 42 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 15 papers in Organic Chemistry and 14 papers in Cancer Research. Recurrent topics in W. Cameron Black's work include Bone Metabolism and Diseases (14 papers), Protease and Inhibitor Mechanisms (13 papers) and Inflammatory mediators and NSAID effects (9 papers). W. Cameron Black is often cited by papers focused on Bone Metabolism and Diseases (14 papers), Protease and Inhibitor Mechanisms (13 papers) and Inflammatory mediators and NSAID effects (9 papers). W. Cameron Black collaborates with scholars based in Canada, United States and France. W. Cameron Black's co-authors include David A. Evans, M. David Percival, Frédéric Massé, Sylvie Desmarais, Serge Léger, Jean‐Pierre Falgueyret, Denis Riendeau, Christopher I. Bayly, Renata M. Oballa and Sonia Lamontagne and has published in prestigious journals such as Journal of the American Chemical Society, Analytical Biochemistry and Journal of Medicinal Chemistry.

In The Last Decade

W. Cameron Black

42 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W. Cameron Black Canada 26 821 781 362 335 264 42 1.9k
Chun Guo China 23 776 0.9× 743 1.0× 152 0.4× 224 0.7× 118 0.4× 69 1.6k
David K. Clawson United States 23 489 0.6× 1.2k 1.5× 112 0.3× 307 0.9× 99 0.4× 40 2.5k
Youla S. Tsantrizos Canada 28 679 0.8× 946 1.2× 227 0.6× 195 0.6× 65 0.2× 83 1.9k
Gurmit Singh India 21 316 0.4× 394 0.5× 214 0.6× 302 0.9× 79 0.3× 70 1.4k
Philip F. Hughes United States 28 501 0.6× 925 1.2× 87 0.2× 105 0.3× 264 1.0× 76 2.0k
Y. Fulmer Shealy United States 27 900 1.1× 1.2k 1.5× 98 0.3× 186 0.6× 72 0.3× 119 2.0k
Kathryn White United States 23 400 0.5× 745 1.0× 71 0.2× 167 0.5× 65 0.2× 38 1.3k
David J. Hosfield United States 28 173 0.2× 2.2k 2.9× 119 0.3× 359 1.1× 241 0.9× 37 3.0k
Joseph M. Covey United States 29 320 0.4× 2.4k 3.0× 148 0.4× 802 2.4× 253 1.0× 88 3.0k
Grazia Gallo Italy 22 281 0.3× 588 0.8× 80 0.2× 199 0.6× 145 0.5× 29 1.4k

Countries citing papers authored by W. Cameron Black

Since Specialization
Citations

This map shows the geographic impact of W. Cameron Black's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Cameron Black with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Cameron Black more than expected).

Fields of papers citing papers by W. Cameron Black

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Cameron Black. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Cameron Black. The network helps show where W. Cameron Black may publish in the future.

Co-authorship network of co-authors of W. Cameron Black

This figure shows the co-authorship network connecting the top 25 collaborators of W. Cameron Black. A scholar is included among the top collaborators of W. Cameron Black based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. Cameron Black. W. Cameron Black is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Black, W. Cameron, et al.. (2022). Testing inter-observer error under a collaborative research framework for studying lithic shape variability. Archaeological and Anthropological Sciences. 14(10). 209–209. 15 indexed citations
2.
Powell, David, W. Cameron Black, Kelly Bleasby, et al.. (2011). Nicotinic acids: Liver-targeted SCD inhibitors with preclinical anti-diabetic efficacy. Bioorganic & Medicinal Chemistry Letters. 21(24). 7281–7286. 15 indexed citations
3.
Kassahun, Kelem, W. Cameron Black, Deborah A. Nicoll‐Griffith, et al.. (2011). Pharmacokinetics and Metabolism in Rats, Dogs, and Monkeys of the Cathepsin K Inhibitor Odanacatib: Demethylation of a Methylsulfonyl Moiety as a Major Metabolic Pathway. Drug Metabolism and Disposition. 39(6). 1079–1087. 25 indexed citations
4.
Isabel, Élise, David Powell, W. Cameron Black, et al.. (2010). Biological activity and preclinical efficacy of azetidinyl pyridazines as potent systemically-distributed stearoyl-CoA desaturase inhibitors. Bioorganic & Medicinal Chemistry Letters. 21(1). 479–483. 24 indexed citations
5.
Black, W. Cameron. (2010). Peptidomimetic Inhibitors of Cathepsin K. Current Topics in Medicinal Chemistry. 10(7). 745–751. 22 indexed citations
6.
Beaulieu, Christian, Élise Isabel, Frédéric Massé, et al.. (2010). Identification of potent and reversible cruzipain inhibitors for the treatment of Chagas disease. Bioorganic & Medicinal Chemistry Letters. 20(24). 7444–7449. 53 indexed citations
7.
Robichaud, Joël, Jean‐François Fournier, Sébastien Gagné, et al.. (2010). Applying the pro-drug approach to afford highly bioavailable antagonists of P2Y14. Bioorganic & Medicinal Chemistry Letters. 21(14). 4366–4368. 44 indexed citations
8.
Boyd, Michael J., Sheldon N. Crane, Joël Robichaud, et al.. (2008). Investigation of ketone warheads as alternatives to the nitrile for preparation of potent and selective cathepsin K inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(3). 675–679. 23 indexed citations
9.
Desmarais, Sylvie, W. Cameron Black, Renata M. Oballa, et al.. (2007). Effect of Cathepsin K Inhibitor Basicity on in Vivo Off-Target Activities. Molecular Pharmacology. 73(1). 147–156. 61 indexed citations
10.
Gauthier, Jacques Yves, W. Cameron Black, Wanda Cromlish, et al.. (2007). The identification of potent, selective, and bioavailable cathepsin S inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(17). 4929–4933. 51 indexed citations
11.
Léger, Serge, Christopher I. Bayly, W. Cameron Black, et al.. (2007). Primary amides as selective inhibitors of cathepsin K. Bioorganic & Medicinal Chemistry Letters. 17(15). 4328–4332. 30 indexed citations
12.
Black, W. Cameron & M. David Percival. (2006). The Consequences of Lysosomotropism on the Design of Selective Cathepsin K Inhibitors. ChemBioChem. 7(10). 1525–1535. 53 indexed citations
13.
Li, Chun Sing, Denis Deschênes, Sylvie Desmarais, et al.. (2006). Identification of a potent and selective non-basic cathepsin K inhibitor. Bioorganic & Medicinal Chemistry Letters. 16(7). 1985–1989. 67 indexed citations
14.
McCann, Margaret E., Eric L. Rickes, Paul Cunningham, et al.. (2005). In vitro effects and in vivo efficacy of a novel cyclooxygenase-2 inhibitor in cats with lipopolysaccharide-induced pyrexia. American Journal of Veterinary Research. 66(7). 1278–1284. 28 indexed citations
15.
Falgueyret, Jean‐Pierre, W. Cameron Black, Wanda Cromlish, et al.. (2004). An activity-based probe for the determination of cysteine cathepsin protease activities in whole cells. Analytical Biochemistry. 335(2). 218–227. 45 indexed citations
16.
Black, W. Cameron, et al.. (2004). Volunteerism as an Occupation and its Relationship to Health and Wellbeing. British Journal of Occupational Therapy. 67(12). 526–532. 38 indexed citations
17.
Black, W. Cameron, Christine Brideau, Chi-Chung Chan, et al.. (2003). 3,4-Diaryl-5-hydroxyfuranones: highly selective inhibitors of cyclooxygenase-2 with aqueous solubility. Bioorganic & Medicinal Chemistry Letters. 13(6). 1195–1198. 29 indexed citations
18.
Black, W. Cameron, Christine Brideau, S. Charleson, et al.. (1999). A new structural variation on the methanesulfonylphenyl class of selective cyclooxygenase-2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 9(22). 3181–3186. 23 indexed citations
19.
Black, W. Cameron, Chi-Chung Chan, Anthony W. Ford‐Hutchinson, et al.. (1995). Cyclooxygenase-2 Inhibitors. Synthesis and Pharmacological Activities of 5-Methanesulfonamido-1-indanone Derivatives. Journal of Medicinal Chemistry. 38(25). 4897–4905. 62 indexed citations
20.
Evans, David A. & W. Cameron Black. (1993). Total synthesis of (+)-A83543A [(+)-lepicidin A]. Journal of the American Chemical Society. 115(11). 4497–4513. 239 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chun Guo Breakdown of academic impact, for papers by David K. Clawson Breakdown of academic impact, for papers by Youla S. Tsantrizos Breakdown of academic impact, for papers by Gurmit Singh Breakdown of academic impact, for papers by Philip F. Hughes Breakdown of academic impact, for papers by Y. Fulmer Shealy Breakdown of academic impact, for papers by Kathryn White Breakdown of academic impact, for papers by David J. Hosfield Breakdown of academic impact, for papers by Joseph M. Covey Breakdown of academic impact, for papers by Grazia Gallo
Rankless by CCL
2026